Menu Search
Equities

Anpario PLC

KI9A:BER

Anpario PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)3.08
  • Today's Change0.02 / 0.65%
  • Shares traded0.00
  • 1 Year change+12.41%
  • Beta--
Data delayed at least 15 minutes, as of May 03 2024 20:33 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Anpario plc is a United Kingdom-based independent manufacturer of natural sustainable feed additives for animal health, nutrition and biosecurity. The Company's main focus is understanding animals' intestinal health and nutrition. Its feed addictive solutions include poultry, ruminant, swine, aqua and feed mill. Its product categories include health & performance, toxin management, feed quality, and hygiene & insect control. Its health & performance products include Orego-Stim Range, Orego-Stim Range (Aqua), pHorce Range, Salkil Range, Optomega Range and Genex Range. Its toxin management products include Anpro Range and Anpro Advance. Its feed quality products include pHorce Range, Salgard Range, Mastercube Range, Moldgard, Oxigard Range and Feedzyme Range. Its hygiene & insect control products include Mitex, Clean & Dry and Credence. Its technologies are sold in over 80 countries through established sales and distribution networks, which includes a number of wholly owned subsidiaries.

  • Revenue in GBP (TTM)31.00m
  • Net income in GBP2.53m
  • Incorporated1997
  • Employees100.00
  • Location
    Anpario PLCManton Wood Enterprise Park,WORKSOP S80 2RSUnited KingdomGBR
  • Phone+44 190 953 7380
  • Fax+44 190 947 8919
  • Websitehttps://www.anpario.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.